Target-Based ADME/Tox Assays
Life Technologies offers a collection of target-based ADME/Tox assays for drug discovery and development to help you determine the metabolic and safety profiles of lead candidates on a high throughput scale.
Featured Target-Based ADME/Tox Assay Categories
Fluorescent substrates and recombinant enzymes to evaluate your compound’s potential impact on P450 activity
GenoMembrane Transporter Vesicles and Transporter-qualified Hepatocytes to facilitate the prediction of your compounds modulation of transport enzyme activity
|Biochemical hERG Assays
Detect hERG channel binding without radioactivity using our Predictor™ hERG Flourescence Polarization Assay Kit ideal for HTS applications
|Nuclear Receptor ADME Assays
Our LanthaScreen® Nuclear Receptor Competitive Binding Assay contains all the needed reagents you need to conduct compound affinity testing
|G-Protein Coupled Receptor Cellular ADME Assays
Avoid off-target effects with our GPCR toxicity panel of validated cellular assays for selectivity screening
Assays to identify indicators of both biochemical and cellular toxicity
|PCR-Based Drug Discovery Assays
Analyze drug discovery-related genes using our real-time PCR arrays
ADME/Tox News - insight into products, techniques, promotions and events
For Research Use Only. Not for use in diagnostic procedures.